Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium "Care for CMMR-D" (C4CMMR-D)

被引:152
作者
Vasen, H. F. A. [1 ,2 ]
Ghorbanoghli, Z. [2 ]
Bourdeaut, F. [3 ]
Cabaret, O. [4 ]
Caron, O. [5 ]
Duval, A. [6 ]
Entz-Werle, N. [7 ]
Goldberg, Y. [8 ]
Ilencikova, D. [9 ]
Kratz, C. P. [10 ]
Lavoine, N. [11 ]
Loeffen, J. [12 ]
Menko, F. H. [13 ]
Muleris, M. [6 ]
Sebille, G. [14 ]
Colas, C. [15 ]
Burkhardt, B. [16 ]
Brugieres, L. [11 ]
Wimmer, K. [17 ]
机构
[1] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, NL-2333 AA Leiden, Netherlands
[2] Netherlands Fdn Detect Hereditary Tumours, Leiden, Netherlands
[3] Inst Curie, Dept Pediat Oncol, Paris, France
[4] Gustave Roussy Canc Inst, Dept Genet, Villejuif, France
[5] Gustave Roussy Canc Inst, Dept Oncogenet, Villejuif, France
[6] Saint Antoine Hosp, INSERM, Team Microsatellite Instabil & Canc, UMRS 938, Paris, France
[7] Univ Hosp, Dept Pediat Oncol, Strasbourg, France
[8] Hadassah Hebrew Med Ctr, Dept Oncol, Sharret Inst, Jerusalem, Israel
[9] Comenius Univ, Sch Med, Univ Childrens Hosp, Dept Pediat, Bratislava, Slovakia
[10] Hannover Med Sch, Dept Pediat Hematol & Oncol, Hannover, Germany
[11] Gustave Roussy Canc Inst, Dept Pediat, Villejuif, France
[12] Radboud Univ Nijmegen, Med Ctr, Dept Pediat Hematol & Oncol, Nijmegen, Netherlands
[13] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands
[14] Gustave Roussy Canc Inst, Dept Dermatol, Villejuif, France
[15] Hop La Pitie Salpetriere, APHP, Dept Genet, Paris, France
[16] Univ Hosp, Dept Pediat Hematol & Oncol, Munster, Germany
[17] Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria
关键词
CMMR-D; Constitutional mismatch repair deficiency; Surveillance; Guidelines; Tumour spectrum; BIALLELIC MSH6 MUTATIONS; COLORECTAL-CANCER CELLS; NON-HODGKIN-LYMPHOMA; LYNCH SYNDROME; COLON-CANCER; MICROSATELLITE-INSTABILITY; NEUROFIBROMATOSIS TYPE-1; CORPUS-CALLOSUM; GENE-MUTATIONS; RECTAL-CANCER;
D O I
10.1136/jmedgenet-2013-102238
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Lynch syndrome (LS) is an autosomal dominant disorder caused by a defect in one of the DNA mismatch repair genes: MLH1, MSH2, MSH6 and PMS2. In the last 15years, an increasing number of patients have been described with biallelic mismatch repair gene mutations causing a syndrome referred to as constitutional mismatch repair-deficiency' (CMMR-D). The spectrum of cancers observed in this syndrome differs from that found in LS, as about half develop brain tumours, around half develop digestive tract cancers and a third develop haematological malignancies. Brain tumours and haematological malignancies are mainly diagnosed in the first decade of life, and colorectal cancer (CRC) and small bowel cancer in the second and third decades of life. Surveillance for CRC in patients with LS is very effective. Therefore, an important question is whether surveillance for the most common CMMR-D-associated cancers will also be effective. Recently, a new European consortium was established with the aim of improving care for patients with CMMR-D. At a workshop of this group held in Paris in June 2013, one of the issues addressed was the development of surveillance guidelines. In 1968, criteria were proposed by WHO that should be met prior to the implementation of screening programmes. These criteria were used to assess surveillance in CMMR-D. The evaluation showed that surveillance for CRC is the only part of the programme that largely complies with the WHO criteria. The values of all other suggested screening protocols are unknown. In particular, it is questionable whether surveillance for haematological malignancies improves the already favourable outcome for patients with these tumours. Based on the available knowledge and the discussions at the workshop, the European consortium proposed a surveillance protocol. Prospective collection of all results of the surveillance is needed to evaluate the effectiveness of the programme.
引用
收藏
页码:283 / 293
页数:11
相关论文
共 65 条
  • [1] Agenesis of the corpus callosum and gray matter heterotopia in three patients with constitutional mismatch repair deficiency syndrome
    Baas, Annette F.
    Gabbett, Michael
    Rimac, Milan
    Kansikas, Minttu
    Raphael, Martine
    Nievelstein, Rutger A. J.
    Nicholls, Wayne
    Offerhaus, Johan
    Bodmer, Danielle
    Wernstedt, Annekatrin
    Krabichler, Birgit
    Strasser, Ulrich
    Nystrom, Minna
    Zschocke, Johannes
    Robertson, Stephen P.
    van Haelst, Mieke M.
    Wimmer, Katharina
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2013, 21 (01) : 55 - 61
  • [2] The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms
    Borie, Claire
    Colas, Chrystelle
    Dartigues, Peggy
    Lazure, Thierry
    Rince, Patricia
    Buhard, Olivier
    Folliot, Patrick
    Chalastanis, Alexandra
    Muleris, Martine
    Hamelin, Richard
    Mercier, Dominique
    Oliveira, Carla
    Seruca, Raquel
    Chadburn, Amy
    Leblond, Veronique
    Barete, Stephane
    Gaidano, Gianluca
    Martin, Antoine
    Gaulard, Philippe
    Flejoul, Jean-Francois
    Raphael, Martine
    Duval, Alex
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (10) : 2360 - 2366
  • [3] Delays in diagnosis of paediatric cancers: a systematic review and comparison with expert testimony in lawsuits
    Brasme, Jean-Francois
    Morfouace, Michele
    Grill, Jacques
    Martinot, Alain
    Amalberti, Rene
    Bons-Letouzey, Catherine
    Chalumeau, Martin
    [J]. LANCET ONCOLOGY, 2012, 13 (10) : E445 - E459
  • [4] The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence
    Burkhardt, B
    Zimmermann, M
    Oschlies, I
    Niggli, F
    Mann, G
    Parwaresch, R
    Riehm, H
    Schrappe, M
    Reiter, A
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2005, 131 (01) : 39 - 49
  • [5] Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment
    Cahill, Daniel P.
    Levine, Kymberly K.
    Betensky, Rebecca A.
    Codd, Patrick J.
    Romany, Candice A.
    Reavie, Linsey B.
    Batchelor, Tracy T.
    Futreal, P. Andrew
    Stratton, Michael R.
    Curry, William T.
    Iafrate, A. John
    Louis, David N.
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (07) : 2038 - 2045
  • [6] Azathioprine-Induced Carcinogenesis in Mice According to Msh2 Genotype
    Chalastanis, Alexandra
    Penard-Lacronique, Virginie
    Svrcek, Magali
    Defaweux, Valerie
    Antoine, Nadine
    Buhard, Olivier
    Dumont, Sylvie
    Fabiani, Bettina
    Renault, Isabelle
    Tubacher, Emmanuel
    Flejou, Jean-Francois
    Riele, Hein Te
    Duval, Alex
    Muleris, Martine
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (22) : 1731 - 1740
  • [7] Charara M, 2004, ANTICANCER RES, V24, P3161
  • [8] Des Guetz G, 2007, ANTICANCER RES, V27, P2715
  • [9] Chemotherapy of MMR-deficient colorectal cancer
    Devaud, N.
    Gallinger, S.
    [J]. FAMILIAL CANCER, 2013, 12 (02) : 301 - 306
  • [10] Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis
    Dorard, Coralie
    de Thonel, Aurelie
    Collura, Ada
    Marisa, Laetitia
    Svrcek, Magali
    Lagrange, Anais
    Jego, Gaetan
    Wanherdrick, Kristell
    Joly, Anne Laure
    Buhard, Olivier
    Gobbo, Jessica
    Penard-Lacronique, Virginie
    Zouali, Habib
    Tubacher, Emmanuel
    Kirzin, Sylvain
    Selves, Janick
    Milano, Gerard
    Etienne-Grimaldi, Marie-Christine
    Bengrine-Lefevre, Leila
    Louvet, Christophe
    Tournigand, Christophe
    Lefevre, Jeremie H.
    Parc, Yann
    Tiret, Emmanuel
    Flejou, Jean-Francois
    Gaub, Marie-Pierre
    Garrido, Carmen
    Duval, Alex
    [J]. NATURE MEDICINE, 2011, 17 (10) : 1283 - U316